Differential expression of hla antigen of HLA anigens on human B-cell lines of normal and malignant origin: A consequence of immune surveillance or a phenotypic vestige of the progenitor cells?

Abstract

Pairs of BL‐derived cell lines and in vitro EBV‐transformed LCLs, derived from the same patient, were compared for the expression of MHC class‐l antigenic determinants as shown both by monoclonal antibody (MAb) binding and by sensitivity to HLA‐specific CTL clones. BL lines expressed all polymorphic determinants tested at a lower level than the corresponding LCLs, as indicated by the binding of the MAbs AUF 5.13 (anti‐HLA A3,AII), GS 142.1 (anti‐HLA Al), GS 114.1 (anti‐HLA A24), GSP 35.1 (anti‐HLA A2.A28), GSP 55.1 (anti‐HLA A25.A32), TER MA32 (anti‐HLA A32), GSP 145.2 (anti‐HLA B27), B27 M.I (anti‐HLA B27,B7) and GSP 8.1 (anti‐HLA B8). The difference was most pronounced for HLA All and least for B27,AI and B8 with intermediate differences for the other specificities. The BL lines were also less sensitive to lysis by HLA‐specific CTL clones directed to the same and to additional antigens. The polymorphic determinants detected by the AUF 5.13 and GSP 35.1. MAbs were expressed at a lower level in resting T and B cells compared to mitogen‐ and EBV‐induced blasts. An analogous change in the expression of polymorphic determinants was observed in EBV‐converted sublines of originally EBV‐negative BLs that have become more “LCL‐like” after conversion. The appearance of B‐cell activation markers was paralleled by the up‐regulation of both the serologically defined and the CTL‐target epitopes. The findings suggest that the low expression of HLA determinants on the BL cells is a phenotypic vestige of the normal BL precursor.